Banco Santander’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $406K | Buy |
+1,245
| New | +$406K | ﹤0.01% | 397 |
|
|
2022
Q2 | – | Sell |
-40,000
| Closed | -$6.53M | – | 369 |
|
|
2022
Q1 | $6.53M | Buy |
+40,000
| New | +$6.53M | 0.07% | 157 |
|
|
2020
Q3 | – | Sell |
-3,429
| Closed | -$508K | – | 352 |
|
|
2020
Q2 | $508K | Buy |
+3,429
| New | +$508K | 0.01% | 273 |
|